CDEK
← All organizations

Lipha

For profitContributed to NME

Also known as: Lipha Pharmaceuticals

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Aug 1, 1997

First marketed drug

Mar 3, 1995

First NDA

Jul 29, 2004

Last known activity

Aug 1, 1997

Acquired by Merck KGaA → Merck Serono on Jan 1, 1991

Timeline

1930s

  1. Jan 1, 1935

    Lipha— Founded

1990s

  1. Jan 1, 1991

    Merck KGaA— Acquired By

  2. Mar 3, 1995

    metformin— NDA Secondary Org

2000s

  1. Jul 29, 2004

    acamprosate— NDA Organization

  2. Jan 1, 2006

    Merck Serono— Now

Drugs by trial phase (2 distinct, 1 trials)

Phase 3 (2 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (2)

Recent trials (1)

Details

Founded
Lyon, FR Jan 1, 1935
First NDA
Jul 29, 2004
Last known activity
Aug 1, 1997

Designations held

  • Priority review